Benzodiazepine Withdrawal

Updated: May 15, 2023

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

melatonin

Indicated for Benzodiazepine Withdrawal in Elderly with Insomnia Administering 2 mg of controlled-release medication orally daily before sleeping for a maximum of 6 months
followed by a gradual reduction of the dosage over a period of 6 weeks

kava

70% of standardized extract
Initial dose-Administer 50mg orally every day followed by
Titrate up over a week while tapering the benzodiazepine over two weeks.
Do not exceed 300 mg/day, titrated over a week.